Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.83 is 46% below its 5-year average of 3.40, near the low end of its 5-year range (0.92–24.66).
As of the fiscal period ended Tuesday, June 30, 2026. 24.96% below its 12-month average of 2.44.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.83.
CURRENT RATIO
1.83
CURRENT RATIO AVG TTM
2.44
CURRENT RATIO AVG 3Y
2.93
CURRENT RATIO AVG 5Y
3.40
CURRENT RATIO AVG 10Y
6.05
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-24.96%
CURRENT VS 3Y AVG
-37.45%
CURRENT VS 5Y AVG
-46.09%
CURRENT VS 10Y AVG
-69.71%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.48
median of 694 covered companies
CURRENT VS SECTOR MEDIAN
-47.29%
vs the sector median at left
Decoy Therapeutics Inc.
Market Cap
$853809.00
Current Ratio
1.83
TTM Avg
2.44
3Y Avg
2.93
5Y Avg
3.40
Market Cap
$873508.00
Current Ratio
8.67
TTM Avg
12.04
3Y Avg
7.97
5Y Avg
19.74
Market Cap
$832324.00
Current Ratio
4.64
TTM Avg
5.46
3Y Avg
4.98
5Y Avg
8.82
Market Cap
$1.04M
Current Ratio
7.99
TTM Avg
0.13
3Y Avg
1.02
5Y Avg
1.02
Market Cap
$1.11M
Current Ratio
3.86
TTM Avg
3.42
3Y Avg
2.60
5Y Avg
2.60
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | $853809.00 | 1.83 | 2.44 | 2.93 | 3.40 |
| Bone Biologics Corporation (BBLG)vs › | $873508.00 | 8.67 | 12.04 | 7.97 | 19.74 |
| GlucoTrack, Inc. (GCTK)vs › | $873967.00 | 0.46 | 3.06 | 2.92 | 4.37 |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $832324.00 | 4.64 | 5.46 | 4.98 | 8.82 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.04M | 7.99 | 0.13 | 1.02 | 1.02 |
| CDT Equity Inc. (CDT)vs › | $678164.00 | 2.14 | 1.09 | 1.79 | 1.48 |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | 4.31 | 1.47 | 1.08 | 7.17 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | 3.86 | 3.42 | 2.60 | 2.60 |
| IM Cannabis Corp. (IMCC)vs › | $1.16M | 0.56 | 0.67 | 0.76 | 1.51 |
| HCW Biologics Inc. (HCWB)vs › | $549273.00 | 0.06 | 0.15 | 3.14 | 7.02 |
Current Ratio
1.83
Quick Ratio
1.83
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.83 |
| 2026-03-31 | 1.84 |
| 2025-12-31 | 2.13 |
| 2025-09-30 | 5.49 |
| 2025-06-30 | 0.92 |
| 2025-03-31 | 1.01 |
| 2024-12-31 | 1.98 |
| 2024-09-30 | 4.09 |
| 2024-06-30 | 2.98 |
| 2024-03-31 | 3.91 |
| 2023-12-31 | 5.02 |
| 2023-09-30 | 3.59 |
| 2023-06-30 | 3.28 |
| 2023-03-31 | 2.21 |
| 2022-12-31 | 3.40 |
| 2022-09-30 | 5.78 |
| 2022-06-30 | 8.31 |
| 2022-03-31 | 11.88 |
| 2021-12-31 | 14.29 |
| 2021-09-30 | 21.82 |
| 2021-06-30 | 24.66 |
| 2021-03-31 | 20.94 |
| 2020-12-31 | 5.70 |
| 2020-09-30 | 5.66 |
| 2020-06-30 | 5.51 |
| 2020-03-31 | 5.28 |
| 2019-12-31 | 1.42 |
| 2019-09-30 | 1.11 |
| 2019-06-30 | 6.86 |
| 2019-03-31 | 8.94 |
| 2018-12-31 | 9.32 |
| 2018-09-30 | 4.74 |
| 2018-06-30 | 4.46 |
| 2018-03-31 | 6.22 |
| 2017-12-31 | 5.91 |
| 2017-09-30 | 8.16 |
| 2017-06-30 | 9.75 |
| 2017-03-31 | 17.04 |
| 2016-12-31 | 16.06 |
| 2016-09-30 | 17.67 |
| 2016-06-30 | 22.78 |
| 2016-03-31 | 28.41 |
| 2015-12-31 | 32.40 |
| 2015-09-30 | 43.13 |
| 2015-06-30 | 50.54 |
| 2015-03-31 | 78.72 |
| 2014-12-31 | 34.40 |
| 2014-09-30 | 48.89 |
| 2014-06-30 | 0.00 |
